Posts Tagged ‘risks’
Metabolic Risks Unmonitored In Medicaid Patients On Antipsychotics
Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals…
Crowded Emergency Departments Pose Greater Risks For Patients With Heart Attacks
Patients with heart attacks and other forms of chest pain are three to five times more likely to experience serious complications after hospital admission when they are treated in a crowded emergency department, according to a new study.
New Medicare Policy May Pose Risks To Black Kidney Patients
A change in Medicare reimbursement policy could make it more difficult for African Americans with kidney disease to access dialysis services, suggests a study in an upcoming issue of the Journal of the American Society of Nephrology (JASN). “The change in payment policy may disadvantage a substantial group of dialysis patients,” comments Areef Ishani, MD (University of Minnesota).
Critical Shortages Of Narcotic Medications Pose Serious Health Risks
The American Society of Consultant Pharmacists (ASCP) called for remedial action to alleviate the dire shortage of narcotic medications used regularly in the treatment of long-term care and hospice patients. In a letter to Joshua M. Sharfstein, MD, Acting Commissioner of the US Food and Drug Administration (FDA), ASCP states concerns regarding a severe, nationwide shortage of appropriate narcotic pain medication for patients in nursing homes and in hospice care.
Study Finds Innappropriate Drug Prescriptions Wasting Millions, Raising Health Risks
A recent study in Oregon suggests that drugs designed for treating the most severe mental illnesses are often prescribed at inappropriately low doses and at considerable expense, for use in conditions where their benefit has not been established. In this case, prescription drugs that might cost as much as $20 to $25 a day were being widely used to treat problems for which they were not FDA-approved.
Study Reviews Health Risks, Economic Burden Of Migraine
A new study published in Value in Health reviews the economic burden of migraine in the U.S. and recent clinical findings of the health risks of this neurological condition. This study traces the history of economic articles published on migraine using the PubMed MEDLINE database and archival searches of relevant articles to identify possible health risks associated with migraines that warrant further study. Migraine affects millions of individuals worldwide.
Rx Drug Compare
Translator
By N2H